TUBA3GP

Across TCGA pan-cancer cohorts, TUBA3GP RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated TUBA3GP data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher TUBA3GP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TUBA3GP expression acts as an unfavorable survival marker, although some lineages such as ACC and KIRP show a favorable association.

LIHC, KICH, and ACC are the cancer types where TUBA3GP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.608	0.798	<.001	93	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	75	view →
ACC	DFS	Median	All	0.771	0.247	<.001	54	view →
KIRC	DFS	Tertile	III,IV	0.475	0.688	.008	50	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	40	view →
KIRP	DFS	Tertile	III,IV	0.905	0.235	.008	33	view →
UCS	OS	Tertile	II,III,IV	0.233	0.627	.005	32	view →
THCA	DFS	Tertile	IV	0.093	0.968	<.001	18	view →
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	18	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.045	12	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
COAD	DFS	Tertile	All	0.495	0.712	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

TUBA3GP–LIHC (OS)

Open the LIHC breakdown →